Sukumar Nagendran's Net Worth
$1.7 Million
Who is Sukumar Nagendran?
Sukumar Nagendran has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include Health Sciences Acquisitions Corp, Taysha Gene Therapies, Inc., Solid Biosciences Inc., and AveXis, Inc..
SEC CIK
Sukumar Nagendran's CIK is 0001665124
Past Insider Trading and Trends
2017 was Sukumar Nagendran's most active year for acquiring shares with 10 total transactions. Sukumar Nagendran's most active month to acquire stocks was the month of May. 2017 was Sukumar Nagendran's most active year for disposing of shares, totalling 37 transactions. Sukumar Nagendran's most active month to dispose stocks was the month of April. 2019 saw Sukumar Nagendran paying a total of $149,999.70 for 42,258 shares, this is the most they've acquired in one year. In 2017 Sukumar Nagendran cashed out on 32,042 shares for a total of $1,403,349.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Health Sciences Acquisitions Corp (IMVT) Snapshot price: $35.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $1.54
President and Head R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,523.28% | 863.62K |
—
|
—
| 897.84K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
| +17.11% | 5K |
$0.68 | $3,400.00 | 34.23K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +52.01% | 10K |
$8.01 | $80,100.00 | 29.23K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 19.23K |
—
|
—
| 19.23K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solid Biosciences Inc. (SLDB) Snapshot price: $7.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +1,612.90% | 32.26K |
$4.65 | $149,999.70 | 34.26K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AveXis, Inc. No price found
Sr. VP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.80K |
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 3.8K |
—
|
—
| 3.8K |
Mar 13
| |||
Form 4
|
—
|
0
|
$72.33 | -$191,741.59 |
0
|
Scheduled
|
Feb 1 - Mar 1
| ||
Form 4
|
—
|
0
|
$68.22 | -$177,092.34 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$64.10 | -$162,431.36 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$56.62 | -$135,819.55 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$59.87 | -$147,367.41 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$57.86 | -$140,231.21 |
0
|
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$55.86 | -$133,101.32 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$55.00 | -$130,029.55 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$50.18 | -$112,870.92 |
0
|
Scheduled
|
Jul 3
| ||
Form 4
|
—
|
0
|
$44.69 | -$93,337.33 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
$49.93 | -$111,992.34 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$47.30 | -$102,692.46 |
0
|
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||